logo
Plus   Neg
Share
Email

Salix, Progenics Say FDA Advisory Committee To Review RELISTOR SNDA

Salix Pharmaceuticals, Ltd., (SLXP), a developer and marketer of prescription products for the prevention and treatment of gastrointestinal diseases, and Progenics Pharmaceuticals (PGNX), a biopharmaceutical company dedicated to developing innovative medicines, Tuesday announced that the FDA is seeking input from an Advisory Committee on Salix's Supplemental New Drug Application or sNDA for RELISTOR (methylnaltrexone bromide) Subcutaneous Injection, for opioid-induced constipation, or OIC, in patients with chronic pain.

The FDA's action to convene an Advisory Committee was taken in response to the formal appeal by Salix of the complete response action taken by the FDA on July 27, 2012 regarding the RELISTOR sNDA for chronic pain. The FDA has said that it will take action under the appeal after receiving input from the Advisory Committee. The FDA will notify the Company once the Advisory Committee meeting date has been determined, Salix said.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines has announced that tickets for the Bombardier CRJ-550 will be available for purchase starting Saturday, October 12 for travel beginning Sunday, October 27. United Airlines also revealed the first 15 routes for the new Bombardier CRJ-550 aircraft. Initially, the CRJ-550 will fly out... Coffee retail giant Starbucks (SBUX) announced its plan to expand its profit-sharing Community Store program in Korea. The company plans to open the first of several locations in early 2020. The country is one of three Starbucks markets with Community Stores, according to a press release. Starbucks... Toyota Motor Corp. has unveiled the second-generation of its hydrogen fuel-cell car, the Mirai, saying it expects the new sedan will help it to realize the goal of a hydrogen energy society. The new Mirai will seat one more than the current model and also features a fully-redesigned fuel cell system that offers up to a 30 percent increase in driving range.
Follow RTT
>